SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BOSTON SCIENTIFIC CORP (BSX) (CIK 0000885725) (BSX) — Jan 14, 2008

BOSTON SCIENTIFIC CORP (BSX) (CIK 0000885725)
Date: Jan. 14, 2008 · CIK: 0000885725 · Accession: 0000000000-08-002348

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-11083

Date
December 7, 2007
Author
Hanna T. Teshome
Form
UPLOAD
Company
BOSTON SCIENTIFIC CORP (BSX) (CIK 0000885725)

Letter

Mail Stop 3561 December 7, 2007 By U.S. Mail and facsimile to (508) 650-8657

James R. Tobin President and Chief Executive Officer Boston Scientific Corporation One Boston Scientific Place Natick, Massachusetts 01760 Re: Boston Scientific Corporation Definitive 14A Filed on March 27, 2007 File no. 001-11083 Dear Mr. Tobin: We have completed our review of your executive compensation and related disclosure, and we have no further comments at this time. Please note that the company is responsib le for the adequacy and accuracy of the disclosure in its filing. We are not approving any proposed disclosure you may have included in your response lette r or any disclosure you include in your future filings in response to our comments.

If you have any further questions regardi ng our review of your filing, please call me at (202) 551-3315. S i n c e r e l y , H a n n a T . T e s h o m e S p e c i a l C o u n s e l

Show Raw Text
Mail Stop 3561
 December 7, 2007
  By U.S. Mail and facsimile to (508) 650-8657

James R. Tobin President and Chief Executive Officer Boston Scientific Corporation One Boston Scientific Place Natick, Massachusetts 01760
Re:      Boston Scientific Corporation
Definitive 14A
Filed on March 27, 2007 File no. 001-11083
 Dear Mr. Tobin:   We have completed our review of your executive compensation and related
disclosure, and we have no further comments at this time.
  Please note that the company is responsib le for the adequacy and accuracy of the
disclosure in its filing.  We  are not approving any proposed  disclosure you may have
included in your response lette r or any disclosure you include in your future filings in
response to our comments.

If you have any further questions regardi ng our review of your filing, please call
me at (202) 551-3315.           S i n c e r e l y ,            H a n n a  T .  T e s h o m e          S p e c i a l  C o u n s e l